Company Overview
Cellicon Lab Co., Ltd. is an innovative platform biotech company that overcomes the limitations of drug delivery. Our competitiveness lies in the following two core assets. First, the 'Bio-Membrane Permeability DDS Platform,' a universal technology that delivers active substances to their destination regardless of the drug's properties or size. Second, 'Reverse-Aging Peptides,' an innovative new material that restores the resilience of aging cells. Having proven its business viability, Cellicon Lab is now advancing its business scope beyond cosmetics into medical devices and pharmaceuticals. Starting with the launch of the Reverse-Aging Skin Booster in the second half of 2026, we are actively expanding our proprietary pipeline and are poised to become a leading company driving the next-generation global bio-healthcare market.
